BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33536912)

  • 1. Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction.
    Rocca MS; Vignoli A; Tenori L; Ghezzi M; De Rocco Ponce M; Vatsellas G; Thanos D; Padrini R; Foresta C; De Toni L
    Front Pharmacol; 2020; 11():602369. PubMed ID: 33536912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.
    Munk NE; Knudsen JS; Comerma-Steffensen S; Simonsen U
    Sex Med Rev; 2019 Jul; 7(3):430-441. PubMed ID: 30711478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Oro-Dispersible Sildenafil in a New Film Formulation for the Treatment of Erectile Dysfunction: Comparison Between Sildenafil 100-mg Film-Coated Tablet and 75-mg Oro-Dispersible Film.
    Cocci A; Capece M; Cito G; Russo GI; Falcone M; Timpano M; Rizzo M; Della Camera PA; Morselli S; Campi R; Sessa F; Cacciamani G; Minervini A; Gacci M; Mirone V; Morelli G; Mondaini N; Polloni G; Serni S; Natali A
    J Sex Med; 2017 Dec; 14(12):1606-1611. PubMed ID: 29153580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors.
    De Toni L; De Rocco Ponce M; Franceschinis E; Dall'Acqua S; Padrini R; Realdon N; Garolla A; Foresta C
    Front Pharmacol; 2018; 9():59. PubMed ID: 29467656
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction in Diabetic Patients.
    Spivak L; Shultz T; Appel B; Verze P; Yagudaev D; Vinarov A
    Sex Med Rev; 2021 Oct; 9(4):619-627. PubMed ID: 31378506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study.
    Garrido-Abad P; Senra-Bravo I; Manfredi C; Fernández-Pascual E; Linares-Espinós E; Fernández-Arjona M; Varillas-Delgado D; Martínez-Salamanca JI
    Int J Impot Res; 2022 Mar; 34(2):164-171. PubMed ID: 33483603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction.
    Rubio-Aurioles E; Reyes LA; Borregales L; Cairoli C; Sorsaburu S
    Curr Med Res Opin; 2013 Jun; 29(6):695-706. PubMed ID: 23540375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness and predictors of success of low-intensity shockwave therapy in phosphodiesterase type 5 inhibitors non-responders.
    Musa ZS; El-Assmy A; Shokry AM; Shokeir AA; Zween T; Al-Kenawy MR
    Arab J Urol; 2020; 18(1):54-58. PubMed ID: 32082635
    [No Abstract]   [Full Text] [Related]  

  • 10. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil.
    Dadkhah F; Safarinejad MR; Asgari MA; Hosseini SY; Lashay A; Amini E
    Int J Impot Res; 2010; 22(1):51-60. PubMed ID: 19865092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penile rehabilitation for postprostatectomy erectile dysfunction.
    Philippou YA; Jung JH; Steggall MJ; O'Driscoll ST; Bakker CJ; Bodie JA; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012414. PubMed ID: 30352488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.
    Jenkins LC; Hall M; Deveci S; Guhring P; Parker M; Nelson CJ; Mulhall JP
    J Sex Med; 2019 Oct; 16(10):1541-1546. PubMed ID: 31444103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
    El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
    Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Outcome Risks in Patients With Erectile Dysfunction Co-Prescribed a Phosphodiesterase Type 5 Inhibitor (PDE5i) and a Nitrate: A Retrospective Observational Study Using Electronic Health Record Data in the United States.
    Nunes AP; Seeger JD; Stewart A; Gupta A; McGraw T
    J Sex Med; 2021 Sep; 18(9):1511-1523. PubMed ID: 34389264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the new 75-mg orodispersible film of sildenafil on erection and sexual quality of life: insights from an observational study.
    Sansone A; Frangione V; Lanzarotti A; Cocci A; Ceruti C; De Sio M; Imbimbo C; Mirone V; Schips L; Terrone C; Jannini EA
    Sex Med; 2023 Apr; 11(2):qfac007. PubMed ID: 36910700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
    Srini VS; Reddy RK; Shultz T; Denes B
    Can J Urol; 2015 Feb; 22(1):7614-22. PubMed ID: 25694008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction.
    Kilic M; Erkan A; Zengin S; Dundar G; Boyaci C
    Investig Clin Urol; 2023 Jul; 64(4):404-411. PubMed ID: 37417566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction.
    Canguven O; Bailen J; Fredriksson W; Bock D; Burnett AL
    J Sex Med; 2009 Sep; 6(9):2561-7. PubMed ID: 19627462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?
    Pozzi E; Capogrosso P; Boeri L; Belladelli F; Baudo A; Schifano N; Abbate C; Dehò F; Montorsi F; Salonia A
    J Sex Med; 2020 Aug; 17(8):1489-1494. PubMed ID: 32340919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea.
    Barbosa FT; Silva MP; Fontes LES; Pachito DV; Melnik T; Riera R
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013169. PubMed ID: 34555186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.